Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2019-04-22 10:51 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
59 - Exercise for cash
|
$-280,200
-11,208 vol $25.00 each |
0 | |
Filed 2019-04-22 10:50 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Options
59 - Exercise for cash
|
-102,683 vol |
0 | |
Filed 2019-04-22 10:49 Tx date 2019-04-17 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$-2,583,225
-103,329 vol $25.00 each |
0 | |
Filed 2019-03-01 Tx date 2019-02-24 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+7,845 vol |
11,208 | |
Filed 2019-01-04 Tx date 2018-12-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+903 vol |
3,363 | |
Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,990 vol |
||
Filed 2018-11-29 Tx date 2018-11-06 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+11,990 vol |
102,683 | |
Filed 2018-10-04 Tx date 2018-09-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+952 vol |
2,460 | |
Filed 2018-07-04 Tx date 2018-06-30 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+807 vol |
1,508 | |
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+701 vol |
||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+701 vol |
701 | |
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+701 vol |
||
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-17 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-16 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-16 Tx date 2018-03-31 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Rights DSU (Deferred Share Units)
56 - Grant of rights
|
+701 vol |
701 | |
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
103,329 | ||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-08-23 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
90,693 | ||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
103,329 | ||
Filed 2017-08-22 Tx date 2017-08-14 |
$CMTA
Clementia Pharmaceuticals Inc. |
Nader, Francois
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
90,693 |